Popular Articles

South American Health Ministers Gather In Argentina To Discuss H1N1 Preparedness
The health ministers of six South American countries gathered in Buenos Aires, Argentina, on Wednesday to "coordinate defenses against" the H1N1 (swine flu) virus which has killed nearly 200 people in the region," the AFP/Google.com reports. Ministers from Argentina, Bolivia, Brazil, Chile, Paraguay and Uruguay used the meeting to voice concern over the rapid spread of the H1N1 virus in their countries, which are now in the southern hemisphere"s winter months, and discuss ways to share supplies to help prevent the spread of the virus. The article includes the individual strategies being taken by some South American countries (7/15).

Nile Therapeutics, Inc. Announces Dosing Of First Patient In Phase 2 Study Of CD-NP For The Treatment Of Acute Heart Failure
Nile Therapeutics, Inc. (Nasdaq: NLTX), a company focused on the development of novel therapeutics for heart failure patients, today announced dosing of its first patient in a Phase 2 clinical study of its lead product, CD-NP, for the treatment of acute heart failure.
News of the day
New Animal Study Of Rexahn's Serdaxin™ Shows Drug's Promise To Treat Anxiety And Depression With Minimal Side Effects
Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), announced the results of a wide-ranging animal study offering more evidence that Serdaxin™ may be an effective therapeutic for the treatment of anxiety disorders in humans. Serdaxin is Rexahn"s leading anxiety and depression drug candidate, and is currently in Phase II clinical trials.
Public Health

Yale Researchers Find Tools Needed To Build A Cellular Shredder

Yale University researchers have discovered a set of cellular chaperones needed to assemble a proteasome, the cellular workhorse that recycles proteins and is crucial for the existence of all eukaryotic cells. Even though proteasomes are a target of new generation of cancer drugs and their malfunction contributes to neurodegenerative diseases such as Alzheimer"s disease, little is known about how this complex machine assembles itself within cells. Working with yeast, a team led by Mark Hochstrasser, Eugene Higgins Professor of Molecular Biophysics & Biochemistry, discovered four factors called assembly chaperones that are crucial to the construction of a key part of the proteasome complex. Their findings are reported in Friday"s edition of the journal Cell. "Our discovery of these factors and their initial characterization is just the first step toward understanding how they operate," Hochstrasser said. "A lot of different proteins have to come together to makes a full proteasome." Proteasomes are a sort of cellular shredder, taking specific proteins within the cell and breaking them apart so they will not block cell proliferation or accumulate to toxic levels. A single mammalian cell might have as many as 800,000 proteasomes. Sometimes, however, proteasomes can shred proteins that would otherwise cause cancer cells to die. A drug that inhibits proteasomes has been approved as a therapy against cancer. Conversely, malfunctions of the proteasome can lead to aggregation of harmful proteins such as those associated with Alzheimer"s disease. Understanding how proteasomes are constructed will help researchers identify mechanisms to intervene in these diseases processes, Hochstrasser said. Other Yale researchers who contributed to the paper are Minoru Funakoshi and Robert J. Tomko Jr. The study was funded by grants from the National Institutes of Health. Citation: Cell: May 29, 2009 Yale University


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):